Monday, November 4, 2013: 5:00 PM-7:00 PM
Capri Ballroom (Marriott Marco Island)
Non-Traditional Flu Vaccine Manufacturing Facility
Erin Kinnevy1, Ian Penkala1, April Soohoo1, John Vogel1, Miriam Wattenbarger1 and Tiffany D. Rau2, (1)Chemical and Biomolecular Engineering, University of Pennsylvania, Philadelphia, PA, (2)Eli Lilly, Lake Charles, LA
Erin Kinnevy1, Ian Penkala1, April Soohoo1, John Vogel1, Miriam Wattenbarger1 and Tiffany D. Rau2, (1)Chemical and Biomolecular Engineering, University of Pennsylvania, Philadelphia, PA, (2)Eli Lilly, Lake Charles, LA
Real-time bioprocess monitor for on-line measurement and control
Chris Evans, ASL Analytical, Coralville, IA
Chris Evans, ASL Analytical, Coralville, IA
Production Mitigation in an Ethanol Fermentation Process
Consuelo Cruz, Research and Development, Archer Daniels Midland Company, Decatur, IL
Consuelo Cruz, Research and Development, Archer Daniels Midland Company, Decatur, IL
Identification and prevention of a colored product variant during recombinant protein production in E. coli
Michael W. Laird1, Wendy Lau2, Jane Gunson1 and Rick St. John3, (1)Late Stage Cell Culture - Pharma Technical Development, Genentech, Inc., South San Francisco, CA, (2)IMP Quality, Genentech, Inc., South San Francisco, CA, (3)Purification Development, Genentech, Inc., South San Francisco, CA
Michael W. Laird1, Wendy Lau2, Jane Gunson1 and Rick St. John3, (1)Late Stage Cell Culture - Pharma Technical Development, Genentech, Inc., South San Francisco, CA, (2)IMP Quality, Genentech, Inc., South San Francisco, CA, (3)Purification Development, Genentech, Inc., South San Francisco, CA
Development of Enhanced Harvest Process Controls to Inhibit Colored Protein-Adduct Formation
Jane Gunson1, Kimberly Kaleas-Carroll2, Deepa Nadarajah2, Rick St. John3 and Michael W. Laird1, (1)Late Stage Cell Culture - Pharma Technical Development, Genentech, Inc., South San Francisco, CA, (2)Purification Development - Pharma Technical Development, Genentech, Inc., South San Francisco, CA, (3)Purification Development, Genentech, Inc., South San Francisco, CA
Jane Gunson1, Kimberly Kaleas-Carroll2, Deepa Nadarajah2, Rick St. John3 and Michael W. Laird1, (1)Late Stage Cell Culture - Pharma Technical Development, Genentech, Inc., South San Francisco, CA, (2)Purification Development - Pharma Technical Development, Genentech, Inc., South San Francisco, CA, (3)Purification Development, Genentech, Inc., South San Francisco, CA
Development of an E .coli Recombinant Protein Fermentation Process
Nitya Krishnan, Late Stage Cell Culture, Pharma Technical Development, Genentech, Inc, South San Francisco, CA and Jane Gunson, Late Stage Cell Culture - Pharma Technical Development, Genentech, Inc., South San Francisco, CA
Nitya Krishnan, Late Stage Cell Culture, Pharma Technical Development, Genentech, Inc, South San Francisco, CA and Jane Gunson, Late Stage Cell Culture - Pharma Technical Development, Genentech, Inc., South San Francisco, CA
Cost-effective biocatalyst manufacture
Matthew Bycroft and Neil Triggs, Chirotech Technology Centre, Dr. Reddy's Laboratories, Cambridge, United Kingdom
Matthew Bycroft and Neil Triggs, Chirotech Technology Centre, Dr. Reddy's Laboratories, Cambridge, United Kingdom
See more of: Posters